SCHEMBL14239222

SCHEMBL14239222

CC(C)(C#N)c1ccc(-n2c(=O)ccc3cnc4ccc(-c5ccc(N)nc5)nc4c32)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CA P42336 18/20 0.59
▸ MTOR P42345 17/20 0.59
▸ PIK3CD O00329 3/20 0.46
▸ PIK3CB P42338 3/20 0.46
▸ PIK3CG P48736 3/20 0.46
▸ PIK3C2A O00443 2/20 0.46
▸ PIK3C2B O00750 2/20 0.46
▸ PIK3R1 P27986 2/20 0.46
▸ PRKDC P78527 2/20 0.46
▸ ATM Q13315 2/20 0.46
▸ ATR Q13535 2/20 0.46
▸ RPTOR Q8N122 2/20 0.46
▸ PIK3C3 Q8NEB9 2/20 0.46
▸ MLST8 Q9BVC4 2/20 0.46
▸ MKNK2 Q9HBH9 1/20 0.46
▸ PI4KB Q9UBF8 1/20 0.46
▸ ALK Q9UM73 2/20 0.44
▸ JAK3 P52333 2/20 0.44
▸ CHEK1 O14757 1/20 0.44
▸ ABCB11 O95342 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20430353 0.90 MTOR (0.73) PIK3CAMTORPIK3CDPIK3CBPIK3CG
SCHEMBL15641504 0.90 PIK3CA (0.49) PIK3CAMTORPIK3CDPIK3CBPIK3CG
SCHEMBL14240428 0.89 PIK3CA (0.59) PIK3CAMTORPIK3CDPIK3CBPIK3CG
SCHEMBL20430570 0.89 PIK3CA (0.61) PIK3CAMTORPIK3CDPIK3CBPIK3CG
SCHEMBL14239224 0.88 MTOR (0.74) PIK3CAMTOR
SCHEMBL14240422 0.88 PIK3CA (0.58) PIK3CAMTORPIK3CDPIK3CBPIK3CG
SCHEMBL18174471 0.88 PIK3CA (0.58) PIK3CAMTORPIK3CDPIK3CBPIK3CG
SCHEMBL18174464 0.87 MTOR (0.57) PIK3CAMTORPIK3CDPIK3CBPIK3CG
SCHEMBL15641463 0.87 MTOR (0.57) PIK3CAMTORPIK3CDPIK3CBPIK3CG
SCHEMBL14239575 0.86 PIK3CA (0.74) PIK3CAMTORPIK3CDPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9475812-B2 Pyridonaphthyridine type dual PI3K and mTOR inhibitor and its preparation and use Xuanzhu Pharma Co., Ltd. (CN) 2016-10-25 — — US claimed
EP-2719697-B1 PYRIDONAPHTHYRIDINE PI3K/MTOR DUAL INHIBITORS AND PREPARATION AND USE THEREOF XUANZHU PHARMA CO LTD (CN) 2018-08-01 — — EP disclosed
EP-2719697-B1 PYRIDONAPHTHYRIDINE PI3K/MTOR DUAL INHIBITORS AND PREPARATION AND USE THEREOF XUANZHU PHARMA CO LTD (CN) 2018-08-01 — — EP disclosed
US-9475812-B2 Pyridonaphthyridine type dual PI3K and mTOR inhibitor and its preparation and use Xuanzhu Pharma Co., Ltd. (CN) 2016-10-25 — — US disclosed
US-9475812-B2 Pyridonaphthyridine type dual PI3K and mTOR inhibitor and its preparation and use Xuanzhu Pharma Co., Ltd. (CN) 2016-10-25 — — US disclosed
US-9475812-B2 Pyridonaphthyridine type dual PI3K and mTOR inhibitor and its preparation and use Xuanzhu Pharma Co., Ltd. (CN) 2016-10-25 — — US disclosed
EP-2719697-A1 PYRIDONAPHTHYRIDINE PI3K/MTOR DUAL INHIBITORS AND PREPARATION AND USE THEREOF Xuanzhu Pharma Co., Ltd. (CN) 2014-04-16 — — EP disclosed
WO-2012167606-A1 PYRIDONAPHTHYRIDINE PI3K/MTOR DUAL INHIBITORS AND PREPARATION AND USE THEREOF 山东亨利医药科技有限责任公司 (CN) 2012-12-13 — — WO disclosed
Send feedback